TSX : AVCN.TO

Avicanna Inc.

$0.125 CAD

$0 (0.0%)

Volume
0
Average Volume
209.79K
Market Capitalization
$15.72M
P/E Ratio
-4.08
Dividend Yield
0.00%
Price Target
Year High
$0.31
Year Low
$0.10
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.96
Company Overview

TSX

Aras Azadian Mba

Drug Manufacturers - Specialty & Generic

Healthcare

AVCN.TO

112

CA

CAD

https://www.avicanna.com

647 243 5283

05368K100

N/A

Liquidity Metrics

0.00

0.96

0.49

0.04

0.00

Sales & Valuation

$25.48M

0.61

3.85

-6.99

-0.02

Profitability

-$0.0248

-$2.84M

-13.90%

-12.09%

-116.09%

-16.26%

P/E Metrics

-4.08

0.08

0.08

Analyst Price Target & Rating

Strong Sell

1/5

0 Analysts

%

Financial Health Scores

-5.04

2/9

-$321.27K

$22.08M

$9.29M

-$3.35M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Ivana Maric Executive Vice President of Marketing
Stephen Kim Chief Legal Officer, General Counsel & Corporate Secretary
Nick Hilborn Chief Financial Officer
Karolina Urban Executive Vice President of Scientific & Medical Affairs
Aras Azadian Mba Co-Founder, Chief Executive Officer & Director
Carlos Enrique Maldonado Muete SVP of Clinical Development
Poll Results

No votes yet today — be the first to share your view!

About Avicanna Inc. (TSX:AVCN.TO) Stock

Avicanna Inc., a biopharmaceutical firm headquartered in Toronto, Canada, and founded in 2016, is actively engaged in the research, development, and commercialization of scientifically validated products for both global medical and consumer health markets. The company's comprehensive scientific framework encompasses R&D and clinical trials, often undertaken in collaboration with Canadian academic and medical institutions. This effort has yielded around twenty commercialized products spanning four primary market categories. These offerings include medical and wellness items under the RHO Phyto brand, featuring cannabinoids such as CBD, CBG, and THC; CBD-infused topical and derma-cosmetic products marketed under the Pura H&W and Pura Earth labels; and bulk cannabis and hemp-derived raw mater ... ials like dried flowers, standardized seeds, full-spectrum extracts, cannabinoid distillates, and isolates, provided through the Aureus brand. Additionally, Avicanna is advancing a pharmaceutical pipeline focused on treatments for conditions including epidermolysis bullosa, dermatological ailments, chronic pain, and various neurological disorders. A notable research partnership with Dr. Christine Allen's Research Group is dedicated to developing a cannabinoid-based therapy for lung inflammation linked to COVID-19.

Avicanna Announces Change in Board of Directors

2026-05-01 20:46:30

TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is announces that Eileen McCormack, who was not on the slate of directors for re-election or election as outlined in the circular at the upcoming annual general and special meeting of shareholders scheduled for Thursday May 7, 2026, has tendered her resignation as a member of the board of directors effective Friday May 1, 2026 ahead of the annual general and special meeting of shareholders.

Frequently Asked Questions

What is the current Avicanna Inc. (AVCN.TO) stock price?

Avicanna Inc.(TSX:AVCN.TO) stock price is $0.125 in the last trading session. During the trading session, AVCN.TO stock reached the peak price of $0.31 while $0.095 was the lowest point it dropped to. The percentage change in AVCN.TO stock occurred in the recent session was 0.0% while the dollar amount for the price change in AVCN.TO stock was $0.

AVCN.TO's industry and sector of operation?

The TSX listed AVCN.TO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of AVCN.TO?

Ivana Maric | Executive Vice President of Marketing
Stephen Kim | Chief Legal Officer, General Counsel & Corporate Secretary
Nick Hilborn | Chief Financial Officer
Karolina Urban | Executive Vice President of Scientific & Medical Affairs
Aras Azadian Mba | Co-Founder, Chief Executive Officer & Director

How many employees does AVCN.TO have?

Number of AVCN.TO employees currently stands at 112. AVCN.TO operates from 480 University Avenue, Toronto, ON M5G 1V2, CA.

Link for AVCN.TO official website?

Official Website of AVCN.TO is: https://www.avicanna.com

How do I contact AVCN.TO?

AVCN.TO could be contacted at phone #647 243 5283 and can also be accessed through its website. AVCN.TO operates from 480 University Avenue, Toronto, ON M5G 1V2, CA.

How many shares of AVCN.TO are traded daily?

The average number of AVCN.TO shares traded daily for last 3 months was 209.79K.

What is the market cap of AVCN.TO currently?

The market value of AVCN.TO currently stands at $15.72M with its latest stock price at $0.125